Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: An 8 week, double-blind, placebo-controlled trial

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 6, 2014, Pages 325-335

  Findling, Robert L ^a,e   Pathak, Sanjeev ^b   Earley, Willie R ^c   Liu, Sherry ^b   DelBello, Melissa P ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b ASTRAZENECA   (United Kingdom)

^c FOREST RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e JOHNS HOPKINS CHILDREN S CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHETAMINE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; DEXAMPHETAMINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPHENIDATE; PLACEBO; PROLACTIN; QUETIAPINE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; DELAYED RELEASE FORMULATION; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADOLESCENT; ADOLESCENT DISEASE; AGITATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CHILD; CHILDHOOD DISEASE; CHILDREN'S DEPRESSION RATING SCALE REVISED; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DSM-IV-TR; EVENING DOSAGE; EXTENDED DRUG RELEASE; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOMANIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT; PARALLEL DESIGN; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEDATION; SIDE EFFECT; SOMNOLENCE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SYSTOLIC BLOOD PRESSURE; THIRST; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; BIPOLAR DISORDER; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; DELAYED-ACTION PREPARATIONS; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; QUETIAPINE FUMARATE; TREATMENT OUTCOME;

EID: 84906541384     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0105     Document Type: Article

References (45)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Bandelow B, Chouinard G, Bobes J, Ahokas A, Eggens I, Liu S, Eriksson H: Extended-release quetiapine fumarate (quetiapine XR): A once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and activecontrolled study. Int J Neuropsychopharmacol 13: 305-320, 2010.
3. Bauer M, El-Khalili N, Datto C, Szamosi J, Eriksson H: A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder. J Affect Disord 127: 19-30, 2010.
4. Biederman J, Joshi G, Mick E, Doyle R, Georgiopoulos A, Hammerness P, Kotarski M, Williams C, Wozniak J: A prospective openlabel trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther 16: 91-102, 2010.
5. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA: Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 166: 42-49, 2009.
6. Buckley PF: Efficacy of quetiapine for the treatment of schizophrenia: A combined analysis of three placebo-controlled trials. Curr Med Res Opin 20: 1357-1363, 2004.
7. Calabrese JR, Keck PE, Jr., Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162: 1351-1360, 2005.
8. Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D: Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: A randomized, double-blind, 3-week trial. Clin Ther 33: 1643-1658, 2011.
9. Del Bello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM: A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. J Clin Psychiatry 68: 789-795, 2007.
10. Del Bello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM: A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord 11: 483-493, 2009.
11. Del Bello MP, Kowatch RA: Pharmacological interventions for bipolar youth: Developmental considerations. Dev Psychopathol 18: 1231-1246, 2006.
12. Del Bello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 45: 305-313, 2006.
13. Emslie GJ: Understanding placebo response in pediatric depression trials. Am J Psychiatry 166: 1-3, 2009.
14. Findling RL: Diagnosis and treatment of bipolar disorder in young patients. J Clin Psychiatry 70: e45, 2009.
15. Findling RL, Pathak S, Earley WR, Liu S, Delbello M: Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: A 26-week, open-label, continuation study. J Child Adolesc Psychopharmacol 23: 490-501, 2013.
16. Geller B, Tillman R, Bolhofner K, Zimerman B, Strauss NA, Kaufmann P: Controlled, blindly rated, direct-interview family study of a prepubertal and early-adolescent bipolar I disorder phenotype: Morbid risk, age at onset, and comorbidity. Arch Gen Psychiatry 63: 1130-1138, 2006.
17. Joshi G, Wozniak J, Petty C, Vivas F, Yorks D, Biederman J, Geller D: Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents. Bipolar Disord 12: 185-195, 2010.
18. Kahn RS, Schulz SC, Palazov VD, Reyes EB, Brecher M, Svensson O, Andersson HM, Meulien D: Efficacy and tolerability of oncedaily extended release quetiapine fumarate in acute schizophrenia: A randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68: 832-842, 2007.
19. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36: 980-988, 1997.
20. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M: Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44: 213-235, 2005.
21. Lewinsohn PM, Klein DN, Seeley JR: Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 34: 454-463, 1995.
22. Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, Faraone SV, Biederman J: Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry 50: 749-762, 2011.
23. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J: Fluoxetine, cognitivebehavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292: 807-820, 2004.
24. McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH: A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 71: 163-174, 2010.
25. National High Blood Pressure Education Program (NHBPEP) Working Group on Hypertension Control in Children and Adolescents: The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Revised May 2005 (Rep. No. NIH Publication 05-5267). Bethesda, MD: National Institutes of Health; 2005.
26. Patel NC, Del Bello MP, Bryan HS, Adler CM, Kowatch RA, Stanford K, Strakowski SM: Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45: 289-297, 2006.
27. Pathak S, Findling RL, Earley WR, Acevedo LD, Stankowski J, Del Bello MP: Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: A 3-week, double-blind, placebo-controlled trial. J Clin Psychiatry 74: e100-e109, 2013.
28. Perlis RH, Dennehy EB, Miklowitz DJ, Del Bello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G: Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: Results from the STEP-BD study. Bipolar Disord 11: 391-400, 2009.
29. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ: The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 168: 1266-1277, 2011.
30. Posner K, Oquendo MA, Gould M, Stanley B, Davies M: Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164: 1035-1043, 2007.
31. Poznanski EO, Cook SC, Carroll BJ: A depression rating scale for children. Pediatrics 64: 442-450, 1979.
32. Poznanski EO, Mokros HB: Manual: Children's Depression Rating Scale-Revised. Los Angeles: Western Psychological Services; 1996. SeroquelXR[US prescribing information].
33. Wilmington, DE: AstraZeneca Pharmaceuticals LP, 2013. Available at http://www1.astrazeneca-us.com/pi/seroquelxr.pdf
34. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res 73: 159-171, 1997.
35. Sullivan AE, Miklowitz DJ: Family functioning among adolescents with bipolar disorder. J Fam Psychol 24: 60-67, 2010.
36. Suppes T, Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D: Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord 121: 106-115, 2010.
37. Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR: Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 26: 600-609, 2006.
38. Erratum in J Clin Psychiatry71: 150-162, 2010.
39. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J: Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 164: 1547-1556, 2007.
40. Vieta E, Mullen J, Brecher M, Paulsson B, Jones M: Quetiapine monotherapy for mania associated with bipolar disorder: Combined analysis of two international, double-blind, randomised, placebocontrolled studies. Curr Med Res Opin 21: 923-934, 2005.
41. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. JAMA 290: 1033-1041, 2003.
42. Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE: A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161: 1079-1083, 2004.
43. Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H: Extended release quetiapine fumarate monotherapy for major depressive disorder: Results of a double-blind, randomized, placebocontrolled study. CNS Spectr 14: 299-313, 2009.
44. Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M: A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71: 150-162, 2010.
45. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133: 429-435, 1978.